S&P Futures
3,899.50 -16.75 (-0.43%) Dow Futures
31,362.00 -125.00 (-0.40%) Nasdaq Futures
12,089.75 -50.75 (-0.42%) Russell 2000 Futures
1,753.50 -8.20 (-0.47%) Crude Oil
105.80 -1.82 (-1.69%) Gold
1,831.80 +1.50 (+0.08%)
10x Genomics, Inc. (TXG)
After hours:
- InvestorPlace
7 Stocks to Buy That Could Make You a Millionaire
Recent declines on Wall Street have been unnerving for most investors. So far in the year the S&P 500 index has lost around 21%. But you can still find some interesting stocks to buy right now. Investing is a long-term strategy that helps many of us prepare for later years. Metrics suggest between 1991 and 2020, the average return for the S&P 500 index has been well over 10%. For instance, let’s assume you are now 35 with $10,000 in savings and you plan to retire at age 65. You decide to invest
- Simply Wall St.
Investors one-year losses grow to 79% as the stock sheds US$652m this past week
The art and science of stock market investing requires a tolerance for losing money on some of the shares you buy. But...
- PR Newswire
10x Genomics Advances Leadership and Innovation in Single Cell and Spatial Technologies at 2022 AGBT General Meeting
10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced a series of product updates that will be presented at the 2022 Advances in Genome Biology and Technology (AGBT) General Meeting this week in Orlando, Fla. The latest developments across 10x Genomics' leading Chromium and Visium platforms and the highly anticipated Xenium launch expected later this year showcase the company's leadership and innovation at the forefront of
